Henan Lingrui Pharmaceutical Co., Ltd. (SHA: 600285)

Market Cap	12.89B
Revenue (ttm)	3.52B
Net Income (ttm)	664.16M
Shares Out	563.16M
EPS (ttm)	1.17
PE Ratio	19.48
Forward PE	18.66
Dividend	0.80 (3.50%)
Ex-Dividend Date	Jun 20, 2024

Volume	4,889,150
Open	23.59
Previous Close	23.52
Day's Range	22.85 - 23.63
52-Week Range	15.37 - 26.89
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2024

About Henan Lingrui Pharmaceutical

Henan Lingrui Pharmaceutical Co., Ltd. produces and sells medicines in China. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, tinctures, etc. covering various product varieties. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, Shenqi Hypoglycemic capsules, and others. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is based in Xinyang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 2,530
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600285

Financial Performance

In 2023, 600285's revenue was 3.31 billion, an increase of 10.31% compared to the previous year's 3.00 billion. Earnings were 568.11 million, an increase of 22.09%.